This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More
 
Ukraine and China Continue to Weigh on Global Indices

Concerns about Chinese growth and the geopolitical fallout of the conflict in Ukraine make for nervous trading on the second day of trading after the Easter break.

Real Money Previews

Jim Cramer: A Couple of Exceptional Earnings Calls

Netflix and Halliburton are two gems that plainly illustrate what's justifying this broad market run.

Jim Cramer: We're Still in the Tech Woods

When people attach such frothy numbers to IPOs, we have problems.

China Economic Data; Scoop on Monitise: Best of Kass

In these highlights from his trading diary in the past week, Doug Kass writes about China's GDP, volatile swings in the market and Monitise.

Mad Money Recap

'Mad Money' Lightning Round: Avoid Stratasys

Cramer likes SolarCity and Manitowoc and prefers Valero over PBF Energy.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

Jim Cramer's Top Stock Picks: NFLX GME HAL KMP

Cramer is a fan of Halliburton and Kinder Morgan Energy Partners but not of GameStop.

'Mad Money' Lightning Round: Avoid Stratasys

Cramer likes SolarCity and Manitowoc and prefers Valero over PBF Energy.

A Beaten-Down Biotech Stock Poised to Perk Up

The biotech sector is back in vogue today. Keep this beaten-down biotech stock on your radar.

Personal Finance

The $9,701 Cup of Coffee: Rethinking Retirement Planning

Is $9,701 a great price for a cup of coffee? It may be, and understanding why can help you think about how your retirement savings translates into retirement income.

Morgan Stanley Says GWPH Pot Stock Is Legit

Morgan Stanley has given GW Pharmaceuticals (GWPH) its vote of confidence, so will this increase confidence in marijuana stocks?

3 Reasons Why Harley Davidson Shines

Sales of motorcycles have continued to ride back from the depths of hell known as the Great Recession. Excluding scooters, sales of motorcycles increased 3% in 2013. In units, however, at 465,000 sold last year, the total remained about 50% below the peak hit in 2007. Industry leader Harley Davidson's shareholders have benefited both from the industry recovery and positive headlines emanating from the company. Here we share some little known secrets.

Why Mixing Dollars and Doctors Is a Healthy Idea

Approximately one-quarter or your retirement expenses will be spent on healthcare so individuals need to save and invest accordingly, says Douglas Wolford, President of Convergent Wealth Advisors. Wolford says one idea is to start shopping early for a concierge doctor or an Accountable Care Organization (ACO). He also suggests procuring long term care insurance well before you need it. Finally, Wolford advocates keeping up with changes in health laws and practicing preventive medicine.

Existing Home Sales Dip 0.2% in March

A second month of a fractional decline in existing home sales kept sales to a 4.59 million annual rate.

Stock Market Today

Market Hustle: Stock Futures Mixed on Weak China Data; Facebook, Apple to Report Earnings

Stock futures are mixed Wednesday amid tepid Chinese economic data.

Beyond Wall St.

Biotech Stocks

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

The Recent Performance of 'Baker Brother Biotech Stocks' is Awful

Healthcare's most closely followed hedge fund is losing money during the biotech bubble burst.

FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?

Someone at Novartis screwed up today by sending out a mass email announcing the FDA approval of a new lung cancer drug ceritinib. Brand name: Zykadia. The only problem is FDA hasn't announced the approval of Zykadia yet.

Deal News

Pershing Square and Valeant's Allergan Deal a Watershed for Activism

Pershing Square Capital Management may be re-writing the rules of activist investing after teaming up with Valeant Pharmaceuticals on a potential takeover of Allergan.

Novartis Reshapes Portfolio via GSK, Eli Lilly Deals

The Swiss company announces four multibillion-dollar transactions including the $16 billion purchase of GlaxoSmithKline's oncology business.

5 Stories You Can't Miss About Big Pharma, Facebook: StockTwits

These stories are generating a ton of social interest and heated debate. Make sure to chime in.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer: Netflix, Halliburton Earnings Are 'Amazing' Stories

Jim Cramer is tired of hearing that there is no revenue growth at Netflix and Halliburton. Cramer thinks Netflix will soon break through its 52-week high and Halliburton is 'on fir...

Herb Greenberg

Greenberg: The Most Important Earnings Lesson from Chipotle

With Chipotle's CMG same-store sales up an astonishing 13.5% during some of the worst winter months in recent or even distant memory: Think twice when you see any company from this...

James Rogers

The Hartford Dives Into IBM Cloud

The Hartford has signed a $500 million, six-year cloud deal with IBM as the tech giant doubles down its efforts to tap into enterprise cloud dollars.

Chris Ciaccia

Where to Get the Nest Thermostat

Following its $3.1 billion acquisition of Nest, Google has just put the Nest Thermostat in the Google Play store.

Laurie Kulikowski

What Comcast Had to Say About Netflix

A squabble between Netflix and Comcast is heating up with the big cable company quickly reacting to Netflix's very public opposition last night of its pending $45-billion takeover ...

Philip van Doorn

Regional Banks Shine at End of Rough Week for Sector

Regional Banks bounced back on Friday, ending a rough week for the banking sector in the wake of the Federal Reserve's stress tests.

Dan Freed

Regions Shares Rise After Modest Earnings Beat

Regions Financial shares rose in early trading Tuesday after first quarter earnings beat estimates by a penny as bad loans cost the bank less than analysts expected.

Adam Feuerstein

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Ted Reed

JetBlue Shares Sit While Most Airline Stocks Soar

JetBlue is a wonderful airline that is loved by its passengers. But its investors aren't so happy.

Rocco Pendola

Beats Music Thinks It's Netflix -- But It's Wrong

The people behind Beats Music should have exercised humility at launch. Now they're just embarrassed.

Anton Wahlman

What Does It Take to Sour on the Electric Car Experience?

Chargers that are always taken all the time have created a nightmare for owners of pure EVs as opposed to plug-in hybrids

Leon Lazaroff

Why Broadcasters' Anger With Aereo Masks Technology Footdragging

Broadcasters complain Aereo is violating copyright law but the case reflects the industry's unwillingness to embrace emergent technologies.

DOW 16,514.37 +65.12 0.40%
S&P 500 1,879.55 +7.66 0.41%
NASDAQ 4,161.4580 +39.9120 0.97%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs